Shalini R: Not All Blood Thinners Are the Same
Shalini R, Registered Nurse at Saudi German Health, shared a post on LinkedIn:
”Notes:10
Not all ‘blood thinners’ are the same – and understanding the difference is key to safer prescribing and better patient outcomes.
This visual highlights the distinction between anticoagulants and antiplatelet agents, two major classes that reduce clot formation through different mechanisms:
Anticoagulants (e.g., warfarin, apixaban, rivaroxaban, dabigatran)
- Work on the coagulation cascade to slow down clot formation
- Commonly used in conditions like atrial fibrillation, DVT, and PE
- Require careful monitoring (especially warfarin)
- Associated with a higher bleeding risk
Antiplatlet drugs (e.g., aspirin, clopidogrel, ticagrelor, prasugrel)
- Prevent platelets from aggregating and forming clots
- Primarily used in arterial disease (e.g., coronary artery disease, stroke prevention)
- Typically lower bleeding risk compared to anticoagulants
Key takeaway:
Anticoagulants target the clotting cascade, while antiplatelets target platelet function-choosing the right class depends on the underlying pathology.
A simple concept, but one that makes a critical difference in clinical decision-making.”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin